---
input_text: "[Oral zinc in Wilson disease--an alternative to D-penicillamine]. Recently
  Brewer et al. reported the possibility of an oral zinc therapy in Wilson's Disease.
  We treated a 19 years old patient with decompensated liver cirrhosis due to Wilson's
  disease with zinc-sulphate. D-Penicillamine had to be withdrawn since proteinuria
  occurred under treatment. After the discontinuation of D-Penicillamine an increase
  of serum copper almost up to normal range was observed; concomitantly urinary copper
  elimination decreased. Under oral zinc sulphate therapy (145 mg/day) a drop of serum
  copper level was achieved and liver function improved: serum albumin, gamma globulins
  and prothrombin time reached normal values. The patient did not complain any side
  effects during oral zinc sulphate therapy. Oral zinc therapy in Wilson's Disease
  may be regarded as an alternative to D-Penicillamine treatment when this drug has
  to be discontinued because of side effects."
raw_completion_output: |-
  primary_disease: Wilson's Disease

  medical_actions: zinc-sulphate therapy; discontinuation of D-Penicillamine

  symptoms: decompensated liver cirrhosis; proteinuria; high serum copper; decreased urinary copper elimination

  chemicals: zinc-sulphate; D-Penicillamine

  action_annotation_relationships: discontinuation of D-Penicillamine PREVENTS proteinuria IN Wilson's Disease; zinc-sulphate therapy (with zinc-sulphate) TREATS decompensated liver cirrhosis IN Wilson's Disease; zinc-sulphate therapy (with zinc-sulphate) TREATS high serum copper IN Wilson's Disease; zinc-sulphate therapy (with zinc-sulphate) TREATS decreased urinary copper elimination IN Wilson's Disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  zinc-sulphate therapy (with zinc-sulphate) TREATS decreased urinary copper elimination IN Wilson's Disease

  ===

extracted_object:
  primary_disease: MONDO:0010200
  medical_actions:
    - zinc-sulphate therapy
    - discontinuation of D-Penicillamine
  symptoms:
    - decompensated liver cirrhosis
    - HP:0000093
    - high serum copper
    - decreased urinary copper elimination
  chemicals:
    - zinc-sulphate
    - CHEBI:7959
  action_annotation_relationships:
    - subject: discontinuation of D-Penicillamine
      predicate: PREVENTS
      object: HP:0000093
      qualifier: MONDO:0010200
      subject_extension: CHEBI:7959
    - subject: zinc-sulphate therapy
      predicate: TREATS
      object: decompensated liver cirrhosis
      qualifier: MONDO:0010200
      subject_qualifier: with zinc-sulphate
      subject_extension: zinc-sulphate
    - subject: zinc-sulphate therapy
      predicate: TREATS
      object: high serum copper
      qualifier: MONDO:0010200
      subject_qualifier: with zinc-sulphate
      subject_extension: zinc-sulphate
    - subject: zinc-sulphate therapy
      predicate: TREATS
      object: decreased urinary copper elimination
      qualifier: MONDO:0010200
      subject_qualifier: with zinc-sulphate
      subject_extension: zinc-sulphate
named_entities:
  - id: MONDO:0010200
    label: Wilson's disease
  - id: MAXO:0001175
    label: Liver transplantation
  - id: HP:0001695
    label: Cardiac arrest
  - id: HP:0001685
    label: Myocardial fibrosis
  - id: HP:0001663
    label: Ventricular fibrillation
  - id: CHEBI:28694
    label: Copper
  - id: CHEBI:18248
    label: Iron
  - id: HP:0002910
    label: abnormal liver functions
  - id: HP:0001394
    label: cirrhosis
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:50868
    label: penicillamine
  - id: MAXO:0000016
    label: Cell therapy
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:30703
    label: Tetrathiomolybdate (TTM)
  - id: HP:0006554
    label: acute liver failure
  - id: CHEBI:35176
    label: Zinc sulphate
  - id: CHEBI:35475
    label: NSAIDs
  - id: MAXO:0009095
    label: zinc therapy
  - id: MAXO:0001298
    label: therapy
  - id: HP:0006579
    label: neonatal jaundice
  - id: HP:0001409
    label: portal hypertension
  - id: HP:0030151
    label: cholangitis
  - id: HP:0002612
    label: congenital hepatic fibrosis
  - id: MONDO:0013282
    label: alpha-1-antitrypsin deficiency
  - id: HP:0001903
    label: anemia
  - id: HP:0001410
    label: liver dysfunction
  - id: CHEBI:39501
    label: trientine
  - id: MAXO:0000070
    label: Hepatic transplantation
  - id: HP:0001399
    label: Hepatic failure
  - id: HP:0004448
    label: fulminant hepatic failure
  - id: HP:0003256
    label: coagulopathy (international normalized ratio >2.0)
  - id: HP:0004445
    label: hepatic encephalopathy (HE)
  - id: HP:0002480
    label: hepatic encephalopathy
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:33281
    label: Antibiotics
  - id: MONDO:0100193
    label: End-stage liver disease
  - id: HP:0100626
    label: End-stage liver disease
  - id: HP:0100660
    label: dyskinesia
  - id: HP:0100022
    label: Movement disorders
  - id: HP:0001337
    label: Tremor
  - id: HP:0001332
    label: Dystonia
  - id: MONDO:0019542
    label: Acute liver failure (ALF)
  - id: CHEBI:27385
    label: CCL4
  - id: MAXO:0000127
    label: Genetic testing
  - id: CHEBI:7959
    label: D-penicillamine
  - id: MAXO:0001017
    label: Vaccination
  - id: HP:0001541
    label: Ascites
  - id: HP:0012398
    label: Peripheral edema
  - id: HP:0001260
    label: dysarthria
  - id: HP:0000708
    label: psychiatric disorders
  - id: HP:0200123
    label: chronic hepatitis
  - id: CHEBI:38161
    label: chelators
  - id: MAXO:0000376
    label: liver biopsy
  - id: HP:0001404
    label: hepatocellular necrosis
  - id: CHEBI:61049
    label: Tacrolimus
  - id: HP:0001744
    label: Splenomegaly
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: HP:0002172
    label: impaired balance
  - id: HP:0001347
    label: hyperreflexia
  - id: HP:0031843
    label: bradyphrenia
  - id: HP:0002362
    label: shuffling gait
  - id: HP:0001621
    label: hypophonia
  - id: CHEBI:37153
    label: Calcineurin inhibitors
  - id: CHEBI:8356
    label: pramipexole
  - id: CHEBI:2618
    label: amantadine
  - id: HP:0000093
    label: proteinuria
